Results per Page:
AMP-ed on HIV prevention
From the McElrath Lab, Vaccine and Infectious Disease Division
‘Action and progress link our globe’
HVTN’s Dr. Daniel Driffin focused on hope in remarks at White House World AIDS Day event
First in-human HIV vaccine to induce virus-specific neutralizing antibodies
From the McElrath Lab, Vaccine and Infectious Disease and Clinical Research Divisions
Vaccine trial volunteer works to empower her community, end HIV
Community Advisory Board member Tasia Baldwin helps raise awareness of the ongoing HIV epidemic and how individuals can get involved in research aimed at ending it
Zeroing in on vaginal microbes that most increase HIV risk
Signature combination of BV bacteria and immune proteins associated with highest risk could help guide prevention
HIV prevention in transition: the potential for private pharmacies to decongest public clinics in Kenya
From the Ortblad research group, Public Health Sciences Division
Exploring the impact of prophylactic treatment on HIV prevention in marginalized communities
From the Meisner research group, Public Health Sciences Division
Revolutionizing HIV Prevention: The Impact of Self-Testing Kits in Kenyan Pharmacies
From the Ortblad research group, Public Health Sciences Division
Obstáculos relacionados con la interseccionalidad para la atención médica del VIH y las ITS en las comunidades transgénero y no binaria del estado de Washington
Del Comité Asesor de Salud Sexual Trans y No Binaria de Seattle (STARS por sus siglas en inglés) y del Grupo Duerr de Resultados, Prevención y Epidemiología del VIH (HOPE por sus siglas en inglés)
Intersectional barriers to HIV/STI healthcare among Washington State transgender and nonbinary communities
From the Seattle Trans and Non-binary Sexual Health (STARS) Advisory Board and the Duerr HIV Outcomes, Prevention and Epidemiology (HOPE) Group
Rethinking the When and Where of HIV PrEP service delivery
From the Ortblad Lab, Public Health Sciences Division
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
Biostatistician Dr. Deborah Donnell named AAAS Fellow
Honor recognizes her key role in HIV prevention studies
Tailoring vaccine trial recruitment to individual communities
From the HVTN, Vaccine and Infectious Disease Division
Preparing for coronavirus in your community
As experts warn of a pandemic, here's what you can do
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Cutting-edge approach maps HIV's escape routes
Atlas of immune-evading HIV mutations could inform design of new treatments, vaccines
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic